Burning Rock Biotech (BNR) Treasury Shares (2019 - 2025)

Burning Rock Biotech's Treasury Shares history runs 5 years deep, the most recent figure standing at $8.1 million for Q4 2025.

• In Q4 2025, Treasury Shares fell 8.44% year-over-year to $8.1 million; the TTM figure through Dec 2025 stood at $8.1 million (down 8.44% YoY), while the FY2025 annual figure was $8.2 million, down 5.64% from the prior year.
• Treasury Shares was $8.1 million for Q4 2025 at Burning Rock Biotech, up from -$8.0 million in the prior quarter.
• In the past five years, Treasury Shares ranged from a high of $467847.9 in Q2 2021 to a low of -$448108.7 in Q4 2022.
• Historically, Treasury Shares has averaged $179040.5 across 5 years, with a median of $420868.3 in 2024.
• The sharpest annual moves came in 2023 and 2025: Treasury Shares tumbled 1569.07% in 2023, then climbed 14.44% in 2025.
• A 5-year view of Treasury Shares shows it stood at -$661000.0 in 2021, then soared by 1353.29% to $8.3 million in 2022, then increased by 10.48% to $9.2 million in 2023, then slipped by 3.77% to $8.8 million in 2024, then retreated by 8.44% to $8.1 million in 2025.
• The last three Treasury Shares figures came in at $8.1 million (Q4 2025), -$8.0 million (Q3 2025), and -$8.5 million (Q2 2025), per Business Quant data.